In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions ...

Investing in stocks remains one of the best ways to accumulate capital over long periods. Companies that can last -- and ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

Obesity was tied with an increased risk of developing 16 health outcomes, a large longitudinal study showed. Risks correlated ...

JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...

Cigna CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only ...

TikTok user Bridget, 37, lost over 100 lbs. after taking a weight loss medication and making lifestyle changes. But the body shaming hasn't stopped.

A large majority of older Americans feel that health insurance—including Medicare—should cover anti-obesity medications, ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

SELF will always acknowledge that “obesity” is both a flawed metric of health and a stigmatizing term. SELF will only talk ...

Key Takeaways - - CMS is expected to issue the 2026 final rate notice for Medicare Advantage (MA) and Part D plans by April 7 ...

Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...